DSAM
UTHR icon

Dock Street Asset Management’s United Therapeutics UTHR Stock Holding History

Dock Street Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,072
Closed -$5.93M – 57
2017
Q4 		$5.93M Buy
40,072
+3,921
+11% +$498K 2.3% 19
2017
Q3 		$4.24M Buy
36,151
+862
+2% +$110K 1.84% 22
2017
Q2 		$4.58M Sell
35,289
-166
-0.5% -$20.7K 2.14% 22
2017
Q1 		$4.8M Buy
35,455
+6,280
+22% +$951K 2.22% 19
2016
Q4 		$4.18M Buy
29,175
+249
+0.9% +$31.8K 2.26% 16
2016
Q3 		$3.42M Buy
+28,926
New +$3.48M 2.36% 17

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Dock Street Asset Management's UTHR Position: Q1 2018 in Review

Dock Street Asset Management sold out of United Therapeutics (UTHR) in Q1 2018, closing a stake of 40,072 shares — an estimated $5.93M sold.

Dock Street Asset Management first reported a position in UTHR in Q3 2016 and held it in 6 quarters. The position peaked at $5.93M in Q4 2017. 374 funds tracked by Wall St. Rank hold UTHR as of Q1 2018.

  • Dock Street Asset Management reported no remaining United Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Dock Street Asset Management sold 40,072 United Therapeutics shares in Q1 2018, an estimated $5.93M.
  • Dock Street Asset Management first reported a position in United Therapeutics in Q3 2016 and held it in 6 quarters.
  • Dock Street Asset Management's United Therapeutics position peaked at $5.93M in Q4 2017.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2018.

Based on Dock Street Asset Management's 13F filing for Q1 2018, filed 24 Apr 2018.